RIBOVAX BIOTECHNOLOGIES SA has a total of 54 patent applications. Its first patent ever was published in 2006. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are THERACLONE SCIENCES INC, ONCOIMMUNE INC and ASCLEPIUMM TAIWAN CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | Brazil | 5 | |
#4 | Republic of Korea | 5 | |
#5 | Australia | 4 | |
#6 | China | 4 | |
#7 | EAPO (Eurasian Patent Organization) | 4 | |
#8 | South Africa | 4 | |
#9 | Canada | 3 | |
#10 | New Zealand | 3 | |
#11 | Norway | 2 | |
#12 | United States | 2 | |
#13 | Hong Kong | 1 | |
#14 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Analysing materials | |
#6 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Funaro Ada | 25 |
#2 | Landolfo Santo | 15 |
#3 | Gribaudo Giorgio | 15 |
#4 | Burioni Roberto | 12 |
#5 | Clementi Massimo | 12 |
#6 | Garotta Gianni | 10 |
#7 | Murphy Marianne | 10 |
#8 | Tomaino Barbara | 8 |
#9 | Novelli Francesco | 8 |
#10 | Cappello Paola | 8 |
Publication | Filing date | Title |
---|---|---|
EP2248825A1 | Antigen binding fragments of an antibody for use in treating and diagnosing ocular diseases | |
ZA200902889B | Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma | |
WO2009024445A1 | Antibodies against human cytomegalovirus (hcmv) | |
EP2173771A1 | Antibodies against human cytomegalovirus (hcmv) | |
BRPI0807084A2 | SPECIFIC ANTIBODIES FOR VARUS VARICELA ZOSTER | |
NZ578413A | Antibodies against human cytomegalovirus (hcmv) | |
AU2007331463A1 | Antibodies against human cytomegalovirus (hCMV) | |
CN101578295A | Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma | |
BRPI0619908A2 | method for immortalizing a cell population, cell population, oligoclonal or monoclonal cell population, cell culture, cell culture supernatant, DNA library, use of a cell population, cell culture, DNA supernatant or library, kit to identify and produce a monoclonal antibody, method to produce a cell culture, and method to produce a monoclonal antibody | |
CN101258243A | Novel phage display technologies |